Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Invested Capital (2016 - 2025)

Historic Invested Capital for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $10.3 million.

  • China Pharma Holdings' Invested Capital rose 3566.54% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 3566.54%. This contributed to the annual value of $8.9 million for FY2024, which is 354.5% up from last year.
  • China Pharma Holdings' Invested Capital amounted to $10.3 million in Q3 2025, which was up 3566.54% from $7.9 million recorded in Q2 2025.
  • China Pharma Holdings' Invested Capital's 5-year high stood at $11.2 million during Q3 2021, with a 5-year trough of $4.7 million in Q4 2022.
  • Over the past 5 years, China Pharma Holdings' median Invested Capital value was $8.4 million (recorded in 2024), while the average stood at $8.3 million.
  • Per our database at Business Quant, China Pharma Holdings' Invested Capital crashed by 5428.55% in 2022 and then surged by 8157.36% in 2023.
  • Over the past 5 years, China Pharma Holdings' Invested Capital (Quarter) stood at $10.3 million in 2021, then tumbled by 54.29% to $4.7 million in 2022, then skyrocketed by 81.57% to $8.6 million in 2023, then grew by 3.54% to $8.9 million in 2024, then increased by 15.48% to $10.3 million in 2025.
  • Its Invested Capital was $10.3 million in Q3 2025, compared to $7.9 million in Q2 2025 and $8.1 million in Q1 2025.